What is AssayQuant Technologies?
AssayQuant Technologies, Inc. is a specialized entity focused on continuous kinase and phosphatase assays, crucial tools for drug discovery. The company provides real-time enzyme activity measurements, aiming to enhance decision-making processes within research environments. Their product portfolio encompasses a wide array of kinase and phosphatase assay kits, alongside custom assay development and profiling services. AssayQuant's technology is primarily targeted at pharmaceutical and biotechnology firms, supporting all stages of preclinical drug discovery, from initial target validation through to lead optimization. By delivering critical kinetic insights, their proprietary PhosphoSens technology empowers researchers to gain a competitive advantage in understanding complex enzyme behaviors and inhibitor mechanisms.
How much funding has AssayQuant Technologies raised?
AssayQuant Technologies has raised a total of $115K across 1 funding round:
Debt
$115K
Debt (2021): $115K with participation from PPP
What's next for AssayQuant Technologies?
With a substantial late-stage funding context, AssayQuant Technologies is poised for significant scaling and market penetration. The recent strategic investment suggests a strong validation of their technology and business model by sophisticated backers. This capital infusion will likely fuel further development of their assay platforms, expansion of their service offerings, and a broader reach into the global pharmaceutical and biotech markets. The company's focus on real-time enzyme activity measurements positions it as a key enabler for accelerating drug development pipelines, potentially leading to new therapeutic breakthroughs.
See full AssayQuant Technologies company page
